Skip to content

Public FDA record

Z-2450-2024: CPT Hip Joint Metal/Polymer Semi-Constrained Cemented Prosthesis, used in Hip Arthroplasty; Item Numbers

Recall record Z-2450-2024 for Zimmer, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2450-2024
Company in FDA record
Zimmer, Inc.
FDA classification date
Jul 30, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Affected product has an increased risk of postoperative perisprosthetic femoral fracture (PFF). The IFU is being updated to reflect the risk of PFF.

Source facts

Action
On July 2, 2024, the firm notified customers through Urgent Medical Device Correction letters. Customers were informed of the increased risk of postoperative periprosthetic femoral fracture (PFF). The firm will be updating the IFU to reflect the risk of PFF, with anticipated release by the end of August 2024. In addition, the firm will begin phasing out the device with a target of December 2024 to stop sales. The latest IFU can be viewed electronically at labeling.zimmerbiomet.com and entering the part number. If you have further questions or concerns, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday, or email CorporateQuality.PostMarket@zimmerbiomet.com. *** UPDATED 9/18/24: Follow-up communication was distributed to impacted US surgeons on September 18, 2024. This updated letter reflected FDA's Medical Device Safety Communication issued on September 17, 2024, which provided additional recommendations on the use of the affected product during the phase out period, including that surgeons should consider using an alternative prosthesis where possible. The FDA Safety Communication can be found here: https://www.fda.gov/medical-devices/safety-communications/zimmer-biomet-cpt-hip-system-femoral-stem-and-increased-risk-thigh-bone-fracture-fda-safety?utm_medium=email&utm_source=govdelivery. The updated letter also includes a plain language communication that may be provided to patients. The firm stated all US surgeons will be transitioned to alternative brands and the CPT Hip System Femoral Stem will be exited in the US by the end of October 2024.
Initiated
2024-07-02
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution.
Recall number
Z-2450-2024
Recall status
Open, Classified
CDRH record ID
208823
FDA classified
2024-07-30
Recall event number
94923

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗